Mohamed Mahmoud
Business Partnerships Manager Klarity Oncology at Klarity.io - Middle East & North Africa region at Klarity.io - N/A, N/A, gb
Mohamed Mahmoud's Colleagues at Klarity.io
Mohamed Mahmoud's Contact Details
N/A
Cairo,Cairo Governorate,Egypt
Klarity.io
Mohamed Mahmoud's Company Details
Klarity is a Covid-19 risk management solution which helps employers bring back employees safely and, in a cost-effective manner. The health data management platform includes individual support and interventions from healthcare professionals. We protect citizen privacy by putting them in control of their personal health information with consent controls for sharing of data and through our partnership with a leading global identify verification solution.We believe that the key for the safety & peace of mind of employees now and during the subsequent return to work is to address employee anxiety about returning to a safe work environment and a significant desire for ongoing testing and health insight. This is achieved through our risk scoring tool which uses explainable AI that provides personal Covid-19 risk assessment to identify vulnerable employees and provide personalized health insight. This is supported by accurate testing to assess employee Covid-19 status. Continuous surveillance and symptom checking can be conducted to inform and reassure employees, whether at home or at work. Our health score stratifies risk within the population to identify the most vulnerable and prioritise those for shielding, testing, preventative treatment, or a vaccine. Increased score accuracy is achieved through additional data (e.g. wearable and GP data), thus enabling citizens to securely access, collate, store & share their health data. Citizens can store & share a variety of testing certificates with the iOS, Android, and web applications. We can enable a scalable programme of at office and in-home testing, verification of results and testing certificates, under the remote supervision of healthcare professionals thereby providing a clearer understanding of the prevalence rate. We can enable further testing, on site or through our global lab network, and clinical consultations as required.